| Board Name | Posts By tonto4 | Post Created |
|---|---|---|
| No results found. | ||
Recent Articles
- Design Therapeutics Engages at Major Healthcare Conference
- CareCloud: Leading the Charge in Healthcare IT Innovations
- Protara Therapeutics Gears Up for Key Investor Conferences Ahead
- Innovative Biopharmaceutical Breakthroughs from Werewolf Therapeutics
- Sysco Announces Upcoming Presentation at Global Consumer Event
- Kelly C. Janzen Joins IES Holdings as Board Member
- Explore Abacus Global Management's Investor Day and Longevity Summit
- CG Oncology's Q1 2025 Insights: Progress and Financial Performance
- Apyx Medical Gains FDA Approval for Revolutionary Body System
- Red Violet to Showcase Innovative Solutions at Investor Event
- ALX Oncology Showcases Breakthrough Antibody-Drug Conjugate
- Revolutionizing Data Center Efficiency with Cryogenic Cooling
- Algorhythm Holdings Expands Fleet for Revenue Growth in Logistics
- Hour Loop Enhances Supply Chains in Response to High Tariffs
- Terri Casey Joins American Oncology Network as HR Leader
- iTeos Discontinues Belrestotug Development Following Analysis
- Key Decisions from TRESU Investment Holding A/S Annual Meeting
- Atomic Minerals Expands Footprint with New Uranium Acquisition
- Hyundai ADM Bio Shifts Focus to Immunotherapy Combinations
- Nayax Achieves Impressive First Quarter Growth and Expansion
- Salimetrics Enhances Testing Capacity Amid New NIH Guidelines
- Polyrizon Ventures into $3.15B Epilepsy Treatment Innovations
- American Tungsten Corp. Announces Upcoming CEO Webinar Event
- MediWound's EscharEx® Outshines Collagenase in Healing Trials
- Humacyte Reports Impressive Growth and New Market Launch Updates
- FAVO Capital Enhances Equity Structure Ahead of Nasdaq Listing
- NeuroOne's Q2 Results Show Remarkable Growth and Future Potential
- Exciting Updates on Stardust Power's Lithium Processing Plans
- Minerva Neurosciences Shares Financial Results and Updates
- Unisync's Q2 2025 Report Highlights Growth in Profitability
- Achieve Life Sciences: Big Steps Towards FDA Approval of Cytisinicline
- Knight Therapeutics to Showcase Innovations at Upcoming Conference
- Maze Therapeutics Engages Investors at Major BioConnect Event
- First Participant Dosed in ACT-EARLY Study of Acoramidis
- BrainsWay's Impressive Q1 2025 Results Boost Growth Prospects
- Anavex Life Sciences Reports Q2 FY 2025 Financial Highlights
- Caliber Hospitality Development Expands Horizons for Growth
- Bicara Therapeutics Business Highlights and Q1 2025 Financial Review
- Mereo BioPharma's 2025 Highlights and Financial Overview Revealed
- Intuitive Machines Exceeds Expectations in Q1 2025 Results
- Jones Soda Unveils Creative Collaboration with Crayola Colors
- Akadeum Enhances Microbubble Technology for Cell Therapy
- V2X Secures U.S. Army Contract for Advanced Training Systems
- MediPharm Labs Provides Insights on Corporate Strategy for Shareholders
- Duchesnay USA Teams Up with MyMenopauseRx for Women's Health
- Purple Pepe Revolutionizes Real Estate Transactions with Crypto
- Wayfair's Fun Chair-Ades Challenge Featuring Blake Griffin
- Alpha Omega Appoints Eric Laychock as Chief Operating Officer
- QinetiQ US Secures $54.3 Million for U.S. Army AI Project
- Bluefors Appoints Kim Povlsen as New CEO to Drive Growth